Summit Investment Advisors »

Merrimack Pharma shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Merrimack Pharma (MACK) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Merrimack Pharma

Tip: Access up to 7 years of quarterly data

All positions including Merrimack Pharma held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merrimack Pharma by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $12k 865 13.41
2023-09-30 $11k 865 12.33
2023-06-30 $11k 865 12.30
2018-03-31 $8.0k 1.1k 7.60
2017-12-31 $11k 1.1k 10.45